SBC Medical to Announce Q4 and Full‑Year 2025 Financial Results
Rhea-AI Summary
SBC Medical (Nasdaq: SBC) will report fourth-quarter and full-year 2025 financial results before U.S. market open on March 27, 2026.
Management will host an earnings conference call on March 27, 2026 at 8:30 a.m. ET with prepared remarks and a Q&A. The earnings release, slides, and archived webcast will be posted on the company investor relations website.
Positive
- None.
Negative
- None.
News Market Reaction – SBC
On the day this news was published, SBC gained 0.85%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Market Reality Check
Peers on Argus
SBC fell 3.55% with below-average volume, while peers showed mixed moves: CRAI -0.83%, ICFI -1.54%, ROMA -5.14%, DGNX +7.21%, FORR +0.65%. No clear sector-wide direction emerges.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Mar 02 | AI leadership update | Positive | +1.0% | Appointment of CTO to lead AI-driven digital transformation across operations. |
| Feb 01 | China partnership | Positive | +7.4% | Strategic alliance to expand Shonan Beauty Clinic brand and medical tourism. |
| Jan 07 | Analyst rating/target | Positive | -0.2% | Buy-Extended rating and $9.00 target following U.S. MedSpa collaboration. |
| Jan 07 | U.S. partnership expansion | Positive | -0.2% | OrangeTwist alliance and acquisition-driven expansion to 24 locations. |
| Jan 05 | Strategic U.S. entry | Positive | +3.9% | Minority investment in OrangeTwist marking formal entry into U.S. market. |
Recent strategic and AI/expansion news has more often been met with positive price reactions, though analyst and partnership headlines on 2026-01-07 saw slight negative divergence.
Over the past several months, SBC has focused on expansion and technology. A January 2026 strategic investment in U.S. MedSpa platform OrangeTwist and related alliances supported U.S. market entry and a multi‑year global growth roadmap, with SBC backing 258 clinics and more than six million annual patient visits. A March 2026 CTO appointment aimed to build an AI‑driven management infrastructure across 283 locations. Against this backdrop, the upcoming Q4 and full‑year 2025 earnings date continues a pattern of regular operational and strategic updates.
Market Pulse Summary
This announcement sets expectations for SBC’s Q4 and full‑year 2025 earnings release and conference call on March 27, 2026. Investors can contextualize the upcoming results against recent U.S. expansion, AI‑driven infrastructure plans, and earlier filings that showed revenue pressure but solid profitability and cash. Key elements to watch include revenue trends, cash flow, and any updated commentary on clinic growth and integration of partnerships such as OrangeTwist.
Key Terms
management services organization medical
investor relations financial
AI-generated analysis. Not financial advice.
IRVINE, Calif., March 13, 2026 (GLOBE NEWSWIRE) -- SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical” or the “Company”), a Management Services Organization operating a wide range of franchise businesses across diverse medical fields, today announced it will release its financial results for the fourth quarter and fiscal year ended December 31, 2025, before U.S. market open on March 27, 2026.
Management will host an earnings conference call on March 27, 2026, at 8:30 a.m. Eastern Time to discuss the Company’s financial performance, operational highlights, and key priorities for 2026. A question‑and‑answer session with analysts and investors will follow the prepared remarks.
Please register in advance for the conference using the link provided below.
https://zoom.us/webinar/register/WN_d1mfdSBSThST4BIiID88aQ
Additionally, the earnings release, accompanying slides, and an archived webcast of this conference call will be available at the Company’s Investor Relations website at https://ir.sbc-holdings.com/
About SBC Medical Group Holdings Incorporated
SBC Medical Group Holdings Incorporated is a Management Services Organization operating a wide range of franchise businesses across diverse medical fields, including advanced aesthetic healthcare, dermatology, orthopedics, fertility treatment, gynecology, dentistry, alopecia treatment (AGA), and ophthalmology. The Company manages a diverse portfolio of clinic brands and is actively expanding its global presence, particularly in the United States and Asia, through both direct operations and medical tourism initiatives. In September 2024, the Company was listed on Nasdaq, and in June 2025, it was selected for inclusion in the Russell 3000® Index, a broad benchmark of the U.S. equity market. Guided by its Group Purpose “Contributing to the well-being of people around the world through medical innovation,” SBC Medical Group Holdings Incorporated continues to provide safe, trusted, and high-quality medical services while further strengthening its international reputation for quality and trust in medical care.
For more information, visit https://sbc-holdings.com
For more insights and updates from SBC Holdings, follow us on LinkedIn.
Forward-Looking Statements
This press release contains forward-looking statements. Forward-looking statements are not historical facts or statements of current conditions, but instead represent only the Company’s beliefs regarding future events and performance, many of which, by their nature, are inherently uncertain and outside of the Company’s control. These forward-looking statements reflect the Company’s current views with respect to, among other things, the Company’s product launch plans and strategies; growth in revenue and earnings; and business prospects. In some cases, forward-looking statements can be identified by the use of words such as “may,” “should,” “expects,” “anticipates,” “contemplates,” “estimates,” “believes,” “plans,” “projected,” “predicts,” “potential,” “targets” or “hopes” or the negative of these or similar terms. The Company cautions readers not to place undue reliance upon any forward-looking statements, which are current only as of the date of this release and are subject to various risks, uncertainties, assumptions, or changes in circumstances that are difficult to predict or quantify. The forward-looking statements are based on management’s current expectations and are not guarantees of future performance. The Company does not undertake or accept any obligation to release publicly any updates or revisions to any forward-looking statements to reflect any change in its expectations or any change in events, conditions, or circumstances on which any such statement is based, except as required by law. Factors that may cause actual results to differ materially from current expectations may emerge from time to time, and it is not possible for the Company to predict all of them; such factors include, among other things, changes in global, regional, or local economic, business, competitive, market and regulatory conditions, and those listed under the heading “Risk Factors” and elsewhere in the Company’s filings with the U.S. Securities and Exchange Commission (the “SEC”), which are accessible on the SEC’s website at www.sec.gov.
Contacts
SBC Medical Group Holdings Incorporated
Hikaru Fukui / Head of IR Department; E-mail: ir@sbc-holdings.com
ICR LLC (US Time)
Bill Zima / Managing Partner; E-mail: bill.zima@icrinc.com
FAQ
When will SBC (SBC) release Q4 and full-year 2025 results?
What time is SBC's earnings conference call on March 27, 2026?
How can investors register for SBC's March 27, 2026 earnings call (SBC)?
Where will SBC post the Q4 and full-year 2025 earnings materials and archive?
Will SBC allow analyst and investor questions during the March 27, 2026 call?
